NO971508L - Analoger av sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitet - Google Patents
Analoger av sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitetInfo
- Publication number
- NO971508L NO971508L NO971508A NO971508A NO971508L NO 971508 L NO971508 L NO 971508L NO 971508 A NO971508 A NO 971508A NO 971508 A NO971508 A NO 971508A NO 971508 L NO971508 L NO 971508L
- Authority
- NO
- Norway
- Prior art keywords
- analogs
- increased stability
- growth factor
- biological activity
- fibroblast growth
- Prior art date
Links
- 102000003971 Fibroblast Growth Factor 1 Human genes 0.000 title 1
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 title 1
- 230000004071 biological effect Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C07K14/501—Fibroblast growth factor [FGF] acidic FGF [aFGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32347394A | 1994-10-13 | 1994-10-13 | |
PCT/US1995/012907 WO1996022369A1 (fr) | 1994-10-13 | 1995-10-12 | Analogues de facteur de croissance du fibroblaste acide a stabilite et activite biologique renforcees |
Publications (2)
Publication Number | Publication Date |
---|---|
NO971508D0 NO971508D0 (no) | 1997-04-03 |
NO971508L true NO971508L (no) | 1997-06-13 |
Family
ID=23259345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO971508A NO971508L (no) | 1994-10-13 | 1997-04-03 | Analoger av sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitet |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0786000A1 (fr) |
JP (1) | JPH10507929A (fr) |
CN (1) | CN1169158A (fr) |
AU (1) | AU3828195A (fr) |
CA (1) | CA2201944C (fr) |
CZ (1) | CZ98097A3 (fr) |
HU (1) | HUT77746A (fr) |
NO (1) | NO971508L (fr) |
SK (1) | SK43297A3 (fr) |
WO (1) | WO1996022369A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0785949B1 (fr) * | 1994-10-13 | 2003-05-02 | Amgen Inc. | Procede pour purifier des facteurs de croissance des keratinocytes |
US6693077B1 (en) | 1995-02-14 | 2004-02-17 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 |
US6077692A (en) | 1995-02-14 | 2000-06-20 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 |
US7232667B2 (en) | 1995-02-14 | 2007-06-19 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 polynucleotides |
US6743422B1 (en) | 1996-10-15 | 2004-06-01 | Amgen, Inc. | Keratinocyte growth factor-2 products |
WO1998039436A2 (fr) * | 1997-03-03 | 1998-09-11 | Eisai Co., Ltd. | Compositions de muteine du facteur de croissance des fibroblastes, et procedes d'utilisation de ces compositions |
US6869927B1 (en) | 1997-12-22 | 2005-03-22 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 formulations |
US6238888B1 (en) | 1997-12-22 | 2001-05-29 | Human Genone Sciences, Inc. | Keratinocyte growth factor-2 formulations |
US6274712B1 (en) | 1997-12-23 | 2001-08-14 | 3-Dimensional Pharmaceuticals, Inc. | Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137 |
IL139380A0 (en) * | 2000-10-31 | 2001-11-25 | Prochon Biotech Ltd | Active variants of fibroblast growth factor |
TWI634898B (zh) * | 2013-10-07 | 2018-09-11 | 雅祥生技醫藥股份有限公司 | 經修飾之人類酸性纖維母細胞生長因子及其組合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2098484A1 (fr) * | 1990-12-18 | 1992-06-19 | Tsutomu Arakawa | Analogues du facteur croissance fibroblaste acide a stabilite et activite biologique accrues |
-
1995
- 1995-10-12 EP EP95936275A patent/EP0786000A1/fr not_active Withdrawn
- 1995-10-12 HU HU9800740A patent/HUT77746A/hu unknown
- 1995-10-12 CZ CZ97980A patent/CZ98097A3/cs unknown
- 1995-10-12 JP JP8517875A patent/JPH10507929A/ja not_active Withdrawn
- 1995-10-12 CA CA002201944A patent/CA2201944C/fr not_active Expired - Lifetime
- 1995-10-12 CN CN95196717A patent/CN1169158A/zh active Pending
- 1995-10-12 SK SK432-97A patent/SK43297A3/sk unknown
- 1995-10-12 AU AU38281/95A patent/AU3828195A/en not_active Abandoned
- 1995-10-12 WO PCT/US1995/012907 patent/WO1996022369A1/fr not_active Application Discontinuation
-
1997
- 1997-04-03 NO NO971508A patent/NO971508L/no unknown
Also Published As
Publication number | Publication date |
---|---|
HUT77746A (hu) | 1998-07-28 |
CA2201944C (fr) | 2002-12-31 |
WO1996022369A1 (fr) | 1996-07-25 |
CN1169158A (zh) | 1997-12-31 |
JPH10507929A (ja) | 1998-08-04 |
AU3828195A (en) | 1996-08-07 |
CZ98097A3 (en) | 1997-12-17 |
SK43297A3 (en) | 1998-01-14 |
EP0786000A1 (fr) | 1997-07-30 |
NO971508D0 (no) | 1997-04-03 |
CA2201944A1 (fr) | 1996-07-25 |
MX9702475A (es) | 1997-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE402957T1 (de) | Analoge des menschlichen interferon-alpha mit niedriger toxizität | |
DE69823046D1 (de) | Praktische in vitro sialylierung von rekombinanten glykpproteinen | |
DK0839196T3 (da) | Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner | |
EA200700533A1 (ru) | Мутантные белки (мутеины) фактора роста фибробластов 21 | |
DE69922043D1 (de) | Glp-1 analoge | |
DE69841105D1 (de) | Chemokine peptide, varianten, derivate und analoge. ihre verwendung in methode für die hemmung oder erhöhung von einer entzündungsreaktion | |
AU4162400A (en) | Derivatives of the b or z domain from staphylococcal protein a (spa) interactingwith at least one domain of human factor viii | |
NZ503850A (en) | April - a novel protein with growth effects | |
DE69133593D1 (de) | Menschliches CNP-Gen und Vorläuferprotein | |
NO971508L (no) | Analoger av sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitet | |
DK0948541T3 (da) | Analoge af PTHrP | |
DE60335726D1 (de) | Chromoprotein und fluoroproteine | |
HUP0002985A2 (hu) | Glicirrizinsavat és legalább egy antivirális hatású proteint tartalmazó vírusellenes gyógyszerkészítmény | |
BR9808376A (pt) | Moléculas bi- ou multifuncionais com base em uma armação de dendroaspina | |
ATE403726T1 (de) | Cytokin-proteinfamilie | |
NO971621L (no) | Keratinocyttvekstfaktoranaloger | |
ATA3552000A (de) | Xylosyltransferase-gen | |
ATE323763T1 (de) | Dna & protein bindende miniatur proteine | |
DK1074264T3 (da) | Inhibitorer for neovaskularisering | |
ATE452903T1 (de) | Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten | |
DK0717048T3 (da) | Cyclohexapeptider og deres blandinger, fremgangsmåde til fremstilling deraf samt deres anvendelse | |
IL162133A0 (en) | Method of increasing protein expression, proteins and polynucleotides | |
ATE238791T1 (de) | Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure als mukolytikum | |
ATE432985T1 (de) | Polypeptide mit aktivität der stimulierung von neutrophilen | |
DK0779297T3 (da) | Antigene peptider med glycinsubstitutioner |